High Risk for VTE in ICU Patients : Role for VTE Prophylaxis
暂无分享,去创建一个
[1] P. Galdós,et al. PROF-ETEV study: prophylaxis of venous thromboembolic disease in critical care units in Spain , 2014, Intensive Care Medicine.
[2] O. Badawi,et al. Thrombosis prophylaxis and mortality risk among critically ill adults. , 2014, Chest.
[3] E. Antman,et al. Edoxaban versus warfarin in patients with atrial fibrillation. , 2013, The New England journal of medicine.
[4] K. Inaba,et al. Measurable outcomes of quality improvement using a daily quality rounds checklist: Two-year prospective analysis of sustainability in a surgical intensive care unit , 2013, The journal of trauma and acute care surgery.
[5] D. Cook,et al. Heparin Thromboprophylaxis in Medical-Surgical Critically Ill Patients: A Systematic Review and Meta-Analysis of Randomized Trials* , 2013, Critical care medicine.
[6] Y. Arabi,et al. Use of intermittent pneumatic compression and not graduated compression stockings is associated with lower incident VTE in critically ill patients: a multiple propensity scores adjusted analysis. , 2013, Chest.
[7] Keiji Tanaka,et al. Current prevention practice for venous thromboembolism in Japanese intensive care units , 2013, Journal of Anesthesia.
[8] M. Crowther,et al. Indications, complications, and management of inferior vena cava filters: the experience in 952 patients at an academic hospital with a level I trauma center. , 2013, JAMA internal medicine.
[9] A. Mebazaa,et al. Rivaroxaban for thromboprophylaxis in acutely ill medical patients. , 2013, The New England journal of medicine.
[10] V. Aboyans,et al. Intermittent pneumatic compression to prevent venous thromboembolism in patients with high risk of bleeding hospitalized in intensive care units: the CIREA1 randomized trial , 2013, Intensive Care Medicine.
[11] T. Spiro,et al. Rivaroxaban for thromboprophylaxis in acutely ill medical patients. , 2013, The New England journal of medicine.
[12] M. Islam,et al. Incidence of deep vein thrombosis and justification of chemoprophylaxis in Indian patients: a prospective study. , 2012, Bangladesh Medical Research Council bulletin.
[13] J. Collen,et al. A simple reminder system improves venous thromboembolism prophylaxis rates and reduces thrombotic events for hospitalized patients 1 , 2012, Journal of thrombosis and haemostasis : JTH.
[14] Elie A Akl,et al. Prevention of VTE in Nonsurgical Patients Antithrombotic Therapy and Prevention of Thrombosis , 9 th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines , 2013 .
[15] Apixaban versus Warfarin in Patients with Atrial Fibrillation , 2012 .
[16] A. Alzeer,et al. Venous thromboembolism in a medical intensive care unit. The effect of implementing clinical practice guidelines. , 2012, Saudi medical journal.
[17] S. Goldhaber,et al. Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients. , 2011, The New England journal of medicine.
[18] K. Ho,et al. Omission of early thromboprophylaxis and mortality in critically ill patients: a multicenter registry study. , 2011, Chest.
[19] D. Atar,et al. Apixaban versus warfarin in patients with atrial fibrillation. , 2011, The New England journal of medicine.
[20] G. Breithardt,et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. , 2011, The New England journal of medicine.
[21] W. Zeng,et al. [The efficacy of intermittent pneumatic compression in the prevention of venous thromboembolism in medical critically ill patients]. , 2011, Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue.
[22] G. Guyatt,et al. Dalteparin versus unfractionated heparin in critically ill patients. , 2011, The New England journal of medicine.
[23] A. Turpie,et al. Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. , 2011, Chest.
[24] J. Ge,et al. Venous thromboembolism risk assessment and thromboprophylaxis among hospitalized acute medical patients in China--the RAMP study. , 2010, Thrombosis research.
[25] K. Inaba,et al. Measurable outcomes of quality improvement using a daily quality rounds checklist: one-year analysis in a trauma intensive care unit with sustained ventilator-associated pneumonia reduction. , 2010, The Journal of trauma.
[26] N. K. Pandey,et al. Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery , 2010, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[27] R. Abbate,et al. Reduction in deep vein thrombosis incidence in intensive care after a clinician education program , 2010, Journal of thrombosis and haemostasis : JTH.
[28] P. Williams,et al. Venous thromboembolism prophylaxis in the critically ill: a point prevalence survey of current practice in Australian and New Zealand intensive care units , 2010 .
[29] Leon Poller,et al. Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.
[30] S. Yusuf,et al. Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.
[31] D. Cook,et al. Low-molecular-weight heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review. , 2009, Journal of critical care.
[32] C. Wilasrusmee,et al. Deep venous thrombosis in surgical intensive care unit: prevalence and risk factors. , 2009, Asian journal of surgery.
[33] A. Shorr,et al. Venous thromboembolism in critically ill patients , 2008, Thrombosis and Haemostasis.
[34] P. Rhee,et al. Measurable outcomes of quality improvement in the trauma intensive care unit: the impact of a daily quality rounding checklist. , 2008, The Journal of trauma.
[35] D. Cook,et al. Venous thromboembolism in critical illness in a community intensive care unit. , 2007, Journal of critical care.
[36] P. Homel,et al. Efficacy of Deep Venous Thrombosis Prophylaxis in the Medical Intensive Care Unit , 2006, Journal of intensive care medicine.
[37] W. Chaboyer,et al. Mechanical thromboprophylaxis in critically ill patients: a systematic review and meta-analysis. , 2006, American journal of critical care : an official publication, American Association of Critical-Care Nurses.
[38] G. Guyatt,et al. Minimizing errors of omission: Behavioural rEenforcement of Heparin to Avert Venous Emboli: The BEHAVE Study* , 2006, Critical care medicine.
[39] L. Bressollette. Eight-Year Follow-Up of Patients With Permanent Vena Cava Filters in the Prevention of Pulmonary Embolism: The PREPIC (Prévention du Risque d’Embolie Pulmonaire par Interruption Cave) Randomized Study , 2005, Circulation.
[40] G. Guyatt,et al. Deep venous thrombosis in medical-surgical critically ill patients: Prevalence, incidence, and risk factors , 2005, Critical care medicine.
[41] Marilyn D Paterno,et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. , 2005, The New England journal of medicine.
[42] M. Giménez-Barcons,et al. Outbreak of Nosocomial Hepatitis C Virus Infection Resolved by Genetic Analysis of HCV RNA , 2002, Journal of Clinical Microbiology.
[43] D. Cook,et al. Venous thromboembolism and its prevention in critical care. , 2002, Journal of critical care.
[44] M. Meade,et al. Venous thromboembolic disease: an observational study in medical-surgical intensive care unit patients. , 2000, Journal of critical care.
[45] S. Goldhaber,et al. Low molecular weight heparin versus minidose unfractionated heparin for prophylaxis against venous thromboembolism in Medical Intensive Care Unit patients A randomized controlled trial , 2000 .
[46] R. Pordes,et al. Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. The Association of Non-University Affiliated Intensive Care Specialist Physicians of France. , 2000, American journal of respiratory and critical care medicine.
[47] Y. Kupfer,et al. Subcutaneous Heparin Prophylaxis Significantly Reduces The Incidence Of Venous Thromboembolic Events In The Critically Ill , 1999 .
[48] F. Barral,et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. , 1998, The New England journal of medicine.
[49] A. Iorio,et al. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. , 1998, The New England journal of medicine.
[50] S. Trottier,et al. Utilization of venous thromboembolism prophylaxis in a medical-surgical ICU. , 1998, Chest.
[51] E. Ingenito,et al. Utilization of venous thromboembolism prophylaxis in the medical intensive care unit. , 1994, Chest.
[52] R. T. Plott,et al. Iatrogenic contamination of multidose vials in simulated use. A reassessment of current patient injection technique. , 1990, Archives of dermatology.
[53] J. Cade. High risk of the critically ill for venous thromboembolism , 1982, Critical care medicine.
[54] R. Spragg,et al. Deep venous thrombosis and pulmonary embolism. Frequency in a respiratory intensive care unit. , 1981, JAMA.